Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Mar;84(5):621–625. doi: 10.1054/bjoc.2000.1655

Telomerase activity in plasma cell dyscrasias

D Xu 1,1, C Zheng 1,1, S Bergenbrant 1, G Holm 1, M Björkholm 1, Q Yi 1,2, A Gruber 1
PMCID: PMC2363791  PMID: 11237381

Abstract

Activation of telomerase is essential for in vitro cellular immortalization and tumorigenesis. In the present study, we investigated telomerase activation and its implications in plasma cell dyscrasias including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM) and plasma cell leukaemia (PCL). All 5 patients with MGUS exhibited normal levels of telomerase activity in their plasma cells. Elevated telomerase activity was found in the samples from 21/27 patients with MM and 4/4 with PCL. In addition, 4 myeloma cell lines all expressed high levels of telomerase activity. The expression of telomerase reverse transcriptase (hTERT) and telomerase RNA template (hTER) was positively associated with the levels of telomerase activity in MM/PCL. Tankyrase expression was upregulated, concomitant with the induction of hTERT and activation of telomerase in MM/PCL. The present findings indicate that MGUS cells may not be immortalized and that activation of telomerase plays a role in the malignant transformation from MGUS to MM. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: hTERT, multiple myeloma, plasma cells, telomerase

Full Text

The Full Text of this article is available as a PDF (60.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avilion A. A., Piatyszek M. A., Gupta J., Shay J. W., Bacchetti S., Greider C. W. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 1996 Feb 1;56(3):645–650. [PubMed] [Google Scholar]
  2. Beattie T. L., Zhou W., Robinson M. O., Harrington L. Reconstitution of human telomerase activity in vitro. Curr Biol. 1998 Jan 29;8(3):177–180. doi: 10.1016/s0960-9822(98)70067-3. [DOI] [PubMed] [Google Scholar]
  3. Bechter O. E., Eisterer W., Pall G., Hilbe W., Kühr T., Thaler J. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Res. 1998 Nov 1;58(21):4918–4922. [PubMed] [Google Scholar]
  4. Bryan T. M., Englezou A., Dalla-Pozza L., Dunham M. A., Reddel R. R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med. 1997 Nov;3(11):1271–1274. doi: 10.1038/nm1197-1271. [DOI] [PubMed] [Google Scholar]
  5. Burns M. A., Johnson B. N., Brahmasandra S. N., Handique K., Webster J. R., Krishnan M., Sammarco T. S., Man P. M., Jones D., Heldsinger D. An integrated nanoliter DNA analysis device. Science. 1998 Oct 16;282(5388):484–487. doi: 10.1126/science.282.5388.484. [DOI] [PubMed] [Google Scholar]
  6. Cong Y. S., Wen J., Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet. 1999 Jan;8(1):137–142. doi: 10.1093/hmg/8.1.137. [DOI] [PubMed] [Google Scholar]
  7. Counter C. M., Gupta J., Harley C. B., Leber B., Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 1995 May 1;85(9):2315–2320. [PubMed] [Google Scholar]
  8. Durie B. G., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975 Sep;36(3):842–854. doi: 10.1002/1097-0142(197509)36:3<842::aid-cncr2820360303>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  9. Hallek M., Bergsagel P. L., Anderson K. C. Multiple myeloma: increasing evidence for a multistep transformation process. Blood. 1998 Jan 1;91(1):3–21. [PMC free article] [PubMed] [Google Scholar]
  10. Harley C. B., Kim N. W., Prowse K. R., Weinrich S. L., Hirsch K. S., West M. D., Bacchetti S., Hirte H. W., Counter C. M., Greider C. W. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol. 1994;59:307–315. doi: 10.1101/sqb.1994.059.01.035. [DOI] [PubMed] [Google Scholar]
  11. Kim N. W., Piatyszek M. A., Prowse K. R., Harley C. B., West M. D., Ho P. L., Coviello G. M., Wright W. E., Weinrich S. L., Shay J. W. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994 Dec 23;266(5193):2011–2015. doi: 10.1126/science.7605428. [DOI] [PubMed] [Google Scholar]
  12. Meyerson M., Counter C. M., Eaton E. N., Ellisen L. W., Steiner P., Caddle S. D., Ziaugra L., Beijersbergen R. L., Davidoff M. J., Liu Q. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 1997 Aug 22;90(4):785–795. doi: 10.1016/s0092-8674(00)80538-3. [DOI] [PubMed] [Google Scholar]
  13. Norrback K. F., Dahlenborg K., Carlsson R., Roos G. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood. 1996 Jul 1;88(1):222–229. [PubMed] [Google Scholar]
  14. Sallinen P., Miettinen H., Sallinen S. L., Haapasalo H., Helin H., Kononen J. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas. Am J Pathol. 1997 Apr;150(4):1159–1164. [PMC free article] [PubMed] [Google Scholar]
  15. Xu D., Gruber A., Peterson C., Pisa P. Supression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia. 1996 Aug;10(8):1354–1357. [PubMed] [Google Scholar]
  16. Xu D., Gruber A., Peterson C., Pisa P. Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Br J Haematol. 1998 Sep;102(5):1367–1375. doi: 10.1046/j.1365-2141.1998.00969.x. [DOI] [PubMed] [Google Scholar]
  17. Yi Q., Dabadghao S., Osterborg A., Bergenbrant S., Holm G. Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells. Blood. 1997 Sep 1;90(5):1960–1967. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES